These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 20100464)

  • 1. Identification of genes related to heart failure using global gene expression profiling of human failing myocardium.
    Min KD; Asakura M; Liao Y; Nakamaru K; Okazaki H; Takahashi T; Fujimoto K; Ito S; Takahashi A; Asanuma H; Yamazaki S; Minamino T; Sanada S; Seguchi O; Nakano A; Ando Y; Otsuka T; Furukawa H; Isomura T; Takashima S; Mochizuki N; Kitakaze M
    Biochem Biophys Res Commun; 2010 Feb; 393(1):55-60. PubMed ID: 20100464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine expression profiling of the myocardium reveals a role for CX3CL1 (fractalkine) in heart failure.
    Husberg C; Nygård S; Finsen AV; Damås JK; Frigessi A; Oie E; Waehre A; Gullestad L; Aukrust P; Yndestad A; Christensen G
    J Mol Cell Cardiol; 2008 Aug; 45(2):261-9. PubMed ID: 18585734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Identification of differentially expressed genes in myocardium of patients with heart failure by human whole genomic oligonucleotide microarray-assisted pathways analysis].
    Wu XX; Wan T; Wu HJ; Zhi G; Xiao CS; Gao CQ; Wu JJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Feb; 37(2):120-5. PubMed ID: 19719986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombospondin-2 is essential for myocardial matrix integrity: increased expression identifies failure-prone cardiac hypertrophy.
    Schroen B; Heymans S; Sharma U; Blankesteijn WM; Pokharel S; Cleutjens JP; Porter JG; Evelo CT; Duisters R; van Leeuwen RE; Janssen BJ; Debets JJ; Smits JF; Daemen MJ; Crijns HJ; Bornstein P; Pinto YM
    Circ Res; 2004 Sep; 95(5):515-22. PubMed ID: 15284191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptomal analysis of failing and nonfailing human hearts.
    Steenman M; Chen YW; Le Cunff M; Lamirault G; Varró A; Hoffman E; Léger JJ
    Physiol Genomics; 2003 Jan; 12(2):97-112. PubMed ID: 12429867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor receptors 1 and 2 differentially regulate survival, cardiac dysfunction, and remodeling in transgenic mice with tumor necrosis factor-alpha-induced cardiomyopathy.
    Higuchi Y; McTiernan CF; Frye CB; McGowan BS; Chan TO; Feldman AM
    Circulation; 2004 Apr; 109(15):1892-7. PubMed ID: 15051641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
    Liao Y; Asakura M; Takashima S; Ogai A; Asano Y; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Kitamura S; Tomoike H; Hori M; Kitakaze M
    Circulation; 2004 Aug; 110(6):692-9. PubMed ID: 15262839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transgenic myocardial overexpression of prokineticin receptor-2 (GPR73b) induces hypertrophy and capillary vessel leakage.
    Urayama K; Dedeoglu DB; Guilini C; Frantz S; Ertl G; Messaddeq N; Nebigil CG
    Cardiovasc Res; 2009 Jan; 81(1):28-37. PubMed ID: 18806277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing the global mRNA expression profile of human atrial and ventricular myocardium with high-density oligonucleotide arrays.
    Ellinghaus P; Scheubel RJ; Dobrev D; Ravens U; Holtz J; Huetter J; Nielsch U; Morawietz H
    J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1383-90. PubMed ID: 15942582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A role for caspase-1 in heart failure.
    Merkle S; Frantz S; Schön MP; Bauersachs J; Buitrago M; Frost RJ; Schmitteckert EM; Lohse MJ; Engelhardt S
    Circ Res; 2007 Mar; 100(5):645-53. PubMed ID: 17303764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac-specific overexpression of diacylglycerol kinase zeta prevents Gq protein-coupled receptor agonist-induced cardiac hypertrophy in transgenic mice.
    Arimoto T; Takeishi Y; Takahashi H; Shishido T; Niizeki T; Koyama Y; Shiga R; Nozaki N; Nakajima O; Nishimaru K; Abe J; Endoh M; Walsh RA; Goto K; Kubota I
    Circulation; 2006 Jan; 113(1):60-6. PubMed ID: 16380548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct functions of junD in cardiac hypertrophy and heart failure.
    Ricci R; Eriksson U; Oudit GY; Eferl R; Akhmedov A; Sumara I; Sumara G; Kassiri Z; David JP; Bakiri L; Sasse B; Idarraga MH; Rath M; Kurz D; Theussl HC; Perriard JC; Backx P; Penninger JM; Wagner EF
    Genes Dev; 2005 Jan; 19(2):208-13. PubMed ID: 15655111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac steroidogenesis and glucocorticoid in the development of cardiac hypertrophy during the progression to heart failure.
    Ohtani T; Mano T; Hikoso S; Sakata Y; Nishio M; Takeda Y; Otsu K; Miwa T; Masuyama T; Hori M; Yamamoto K
    J Hypertens; 2009 May; 27(5):1074-83. PubMed ID: 19349910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of tumor necrosis factor- alpha activates both anti- and pro-apoptotic pathways in the myocardium.
    Kubota T; Miyagishima M; Frye CS; Alber SM; Bounoutas GS; Kadokami T; Watkins SC; McTiernan CF; Feldman AM
    J Mol Cell Cardiol; 2001 Jul; 33(7):1331-44. PubMed ID: 11437539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin and angiotensin receptors in cardiac fibroblasts coregulate adrenergic-dependent cardiac hypertrophy.
    Jaffré F; Bonnin P; Callebert J; Debbabi H; Setola V; Doly S; Monassier L; Mettauer B; Blaxall BC; Launay JM; Maroteaux L
    Circ Res; 2009 Jan; 104(1):113-23. PubMed ID: 19023134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of the inducible 70-kDa heat shock protein genes in mice impairs cardiac contractile function and calcium handling associated with hypertrophy.
    Kim YK; Suarez J; Hu Y; McDonough PM; Boer C; Dix DJ; Dillmann WH
    Circulation; 2006 Jun; 113(22):2589-97. PubMed ID: 16735677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphatase inhibitor-1-deficient mice are protected from catecholamine-induced arrhythmias and myocardial hypertrophy.
    El-Armouche A; Wittköpper K; Degenhardt F; Weinberger F; Didié M; Melnychenko I; Grimm M; Peeck M; Zimmermann WH; Unsöld B; Hasenfuss G; Dobrev D; Eschenhagen T
    Cardiovasc Res; 2008 Dec; 80(3):396-406. PubMed ID: 18689792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sepsis affects cardiac expression of multidrug resistance protein 5 (MRP5, ABCC5), an ABC-type CGMP export pump.
    Meissner K; Kessler W; Meyer zu Schwabedissen HE; Schuster K; Saalfeld K; Grube M; Buck A; Jedlitschky G; Maier S; Traeger T; Mostertz J; Homuth G; Heidecke CD; Lehmann C; Kroemer HK
    Shock; 2007 Nov; 28(5):564-9. PubMed ID: 17589384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of adenosine receptor signaling and metabolism on pathophysiology in patients with chronic heart failure.
    Asakura M; Asanuma H; Kim J; Liao Y; Nakamaru K; Fujita M; Komamura K; Isomura T; Furukawa H; Tomoike H; Kitakaze M
    Hypertens Res; 2007 Sep; 30(9):781-7. PubMed ID: 18037770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulator of G-protein signaling subtype 4 mediates antihypertrophic effect of locally secreted natriuretic peptides in the heart.
    Tokudome T; Kishimoto I; Horio T; Arai Y; Schwenke DO; Hino J; Okano I; Kawano Y; Kohno M; Miyazato M; Nakao K; Kangawa K
    Circulation; 2008 May; 117(18):2329-39. PubMed ID: 18443239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.